---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-120650"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2024-11-19T23:59:59+00:00"
generated_at: "2026-05-29T22:30:01.073224+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# Senseonics updates corporate presentation at Stifel Healthcare Conference

## Summary
- Presentation highlights Eversense 365 CGM system FDA clearance and commercial launch.
- Collaboration with Mercy Health targeting up to 30,000 patients initiated Q3 2024, expansion expected 2025.
- Gemini (self-powered) and Freedom (no transmitter) development programs progressing with IDE filing planned 2025.
- CGM market opportunity described as $20B+ US TAM with ~21% CAGR.

## SEC filing metadata
- accession: 0001104659-24-120650
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2024-11-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/0001104659-24-120650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/tm2428905d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-120650
- JSON: https://secwatch.observer/filing/0001104659-24-120650.json
- Plain text: https://secwatch.observer/filing/0001104659-24-120650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.